HDGF Knockout Suppresses Colorectal Cancer Progression and Drug Resistance by Modulating the DNA Damage Response
Biomolecules · 2025
DOI: 10.3390/biom15020282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Riya Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA Damage, Drug Resistance, Neoplasm, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Inner Mongolia Autonomous Region.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a highly heterogeneous gastrointestinal malignancy. Despite significant advances in molecular targeted therapies for CRC in recent years, the increase in the overall survival rates for CRC patients remains limited. Therefore, there is an urgent need to explore novel drug targets. Herein, we show that heparin binding growth factor (HDGF) is highly expressed in CRC, and that its overexpression is associated with a poor disease-free interval. Additionally, we reveal that HDGF knockout reduces proliferation, migration, and invasion, while enhancing apoptosis in CRC cells, thereby validating HDGF as a potential therapeutic target for CRC. Mechanistically, we found that HDGF modulates DNA damage response and, by recruiting C-terminal binding protein-interacting protein (CtIP), it facilitates homologous recombination repair to influence CRC drug sensitivity. Furthermore, we propose that HDGF may serve as a recognition protein for H3K36me3, participating in the repair of damaged transcriptionally active genes, thus maintaining genomic stability in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
- Department of Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010030, China.
- The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, School of Life Sciences, Inner Mongolia University, Hohhot 010020, China.
ORCID-Profile: Kexin Li, Changshan Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Inner Mongolia Autonomous Region
Zitieren
APA
Su, R., Wang, Q., Hu, Q., Wendurige, Li, K., Wang, C., & Tao, L. (2025). HDGF Knockout Suppresses Colorectal Cancer Progression and Drug Resistance by Modulating the DNA Damage Response. Biomolecules. https://doi.org/10.3390/biom15020282
Vancouver
Su R, Wang Q, Hu Q, Wendurige, Li K, Wang C, et al. HDGF Knockout Suppresses Colorectal Cancer Progression and Drug Resistance by Modulating the DNA Damage Response. Biomolecules. 2025. doi:10.3390/biom15020282
BibTeX
@article{Su2025,
author = {Su, Riya and Wang, Qin and Hu, Qun and Wendurige and Li, Kexin and Wang, Changshan and Tao, Liang},
title = {HDGF Knockout Suppresses Colorectal Cancer Progression and Drug Resistance by Modulating the DNA Damage Response},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15020282}
}
EUVIMED